Slimovitch Rachel, Shing Jaimie Z, Fantin Romain, Vanegas Juan C, Porras Carolina, Herrero Rolando, Shiels Meredith S, Sierra Mónica S, Stephens Erica S, Hildesheim Allan, Kreimer Aimée R, Calderón Alejandro, Carvajal Loretto J
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Lancet Reg Health Am. 2024 Aug 27;38:100872. doi: 10.1016/j.lana.2024.100872. eCollection 2024 Oct.
There has been an increase in certain cancers among young adults (YA) aged 20-39, particularly in Latin America. This is the first study to examine cancer incidence and mortality in YA in Costa Rica, focusing on sex-specific patterns.
Invasive cancer cases (excluding non-melanoma skin cancer) in YA from 2006 to 2015 were obtained from the Costa Rican National Registry of Tumors. Utilising SEER∗Stat software, age-standardized incidence rates (IRs) and incidence rate ratios (IRRs) were calculated. Trends and annual percent changes (APCs) in IRs were estimated using the Joinpoint regression analysis program. Cancer deaths from 2000 to 2021 were obtained from the Costa Rican National Institute of Statistics and Census. Age-standardised mortality rates were calculated using STATA®17.
YA comprised 10.7% of all invasive cancer cases diagnosed from 2006 to 2015. The age-standardized incidence rate (ASIR) of invasive cancer in YA was 50.9/100,000 person-years. The ASIR was twofold higher for females compared to males (IRR = 2.03, 95% CI:1.94, 2.13). This difference increased with age, peaking in the 35-39-year age group (IRR = 2.84, 95% CI:2.62, 3.10). Thyroid, breast, and cervical cancer were the most common in females. Testicular cancer was the most common in males. Leading causes of cancer-related deaths included cervical and breast cancer in females and stomach and brain/nervous system cancer in males.
The study highlights sex-specific patterns in cancer incidence and mortality among YA in Costa Rica to increase understanding and improve cancer outcomes in this age group.
This study was funded by the Intramural Research Program of the National Cancer Institute.
20至39岁的年轻成年人(YA)中某些癌症的发病率有所上升,在拉丁美洲尤为明显。这是第一项研究哥斯达黎加年轻成年人癌症发病率和死亡率的研究,重点关注性别特异性模式。
2006年至2015年期间哥斯达黎加年轻成年人的侵袭性癌症病例(不包括非黑色素瘤皮肤癌)来自哥斯达黎加国家肿瘤登记处。使用SEER∗Stat软件计算年龄标准化发病率(IRs)和发病率比(IRRs)。使用Joinpoint回归分析程序估计IRs的趋势和年度百分比变化(APCs)。2000年至2021年的癌症死亡数据来自哥斯达黎加国家统计和普查局。使用STATA®17计算年龄标准化死亡率。
2006年至2015年诊断出的所有侵袭性癌症病例中,年轻成年人占10.7%。年轻成年人侵袭性癌症的年龄标准化发病率(ASIR)为每10万人年50.9例。女性的ASIR是男性的两倍(IRR = 2.03,95% CI:1.94,2.13)。这种差异随着年龄的增长而增加,在35至39岁年龄组达到峰值(IRR = 2.84,95% CI:2.62,3.10)。甲状腺癌、乳腺癌和宫颈癌是女性中最常见的癌症。睾丸癌是男性中最常见的癌症。癌症相关死亡的主要原因包括女性的宫颈癌和乳腺癌以及男性的胃癌和脑/神经系统癌。
该研究突出了哥斯达黎加年轻成年人癌症发病率和死亡率的性别特异性模式,以增进对这一年龄组的了解并改善癌症治疗结果。
本研究由美国国立癌症研究所的内部研究项目资助。